SYNH - FivepHusion team up with Treehill Partners and Syneos Health
2023-05-26 07:00:26 ET
-
FivepHusion has collaboration with Treehill Partners, a New York-based strategic and financial advisory firm specializing in healthcare industry transactions, and Syneos Health ( NASDAQ: SYNH ) to develop and bring a novel, enhanced chemotherapeutic product to market.
-
The integration supports FivepHusion's global development and commercialization strategy.
- The collaboration is designed to strategically and optimally progress development and commercialization of FivepHusion's enhanced chemotherapeutic formulation Deflexifol™ in global markets.
For further details see:
FivepHusion team up with Treehill Partners and Syneos Health